Yıldırım Aytül Belgi, Kılınç Ali Yaşar
Department of Cardiology, Akdeniz University Faculty of Medicine, Antalya, Turkey.
Turk Kardiyol Dern Ars. 2017 Sep;45(Suppl 5):17-21. doi: 10.5543/tkda.2017.92770.
Although the definition of polypharmacy is not yet clear today, it is generally regarded as drug use more than the patient needs. Advanced age is the most important risk factor for polypharmacy. In addition, other risk factors are loss of current cognitive functions, low socioeconomic level and nursing care. It is seen in about 40% of people over 75 years of age worldwide, varying between countries of extreme poverty. Incorrect drug use, drug side effects and drug-drug interaction lead to unwanted hospitalizations. In particular, cardiovascular drugs pose risks in terms of drug side effects in advanced ages. Altering the pharmacokinetics and pharmacodynamics of the drug along with advanced age lead to more frequent side effects or no effect of the drugs. The most important point to prevent polypharmacy is to inform the patient or the patient's caregiver fully and to target treatment with a minimum number of drugs and doses.
尽管如今多重用药的定义尚不明确,但一般认为它是指药物使用超出了患者的需求。高龄是多重用药最重要的风险因素。此外,其他风险因素包括当前认知功能丧失、社会经济水平低和护理情况。全球75岁以上人群中约40%存在多重用药情况,在极端贫困国家之间有所不同。不正确的药物使用、药物副作用和药物相互作用会导致不必要的住院治疗。特别是,心血管药物在高龄时会带来药物副作用方面的风险。随着年龄增长,药物的药代动力学和药效学发生改变,导致药物副作用更频繁或药物无效。预防多重用药最重要的一点是充分告知患者或患者的护理人员,并以最少的药物数量和剂量进行靶向治疗。